The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients

E Zitt1, A H Kirsch, M Haueis

  • 1Department of Internal Medicine IV, Nephrology and Hypertension, Innsbruck Medical University, Innsbruck, Austria.

Clinical Nephrology
|March 24, 2011
PubMed

Insights

The parathyroid hormone (PTH) ratio may help predict cardiovascular events in hemodialysis patients. A higher PTH ratio is linked to increased cardiovascular risk, suggesting its utility in risk assessment.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in hemodialysis patients.
  • The parathyroid hormone (PTH) (1-84)/non-PTH (1-84) ratio (PTH ratio) is a novel biomarker.
  • The potential of the PTH ratio to assess cardiovascular risk in this population remains unclear.

Purpose of the Study:

  • To investigate the association between the PTH ratio and cardiovascular events (CVE) in hemodialysis patients.
  • To determine if the PTH ratio can serve as a predictor of cardiovascular risk.

Main Methods:

  • Prospective cohort study of 70 prevalent hemodialysis patients followed for up to 4 years.
  • Baseline PTH ratio measurement.
  • Primary outcomes: cardiovascular events (CVE) and all-cause mortality.
  • Cox proportional hazards modeling to assess risk association.

Main Results:

  • A PTH ratio > 1 was observed in 49% of patients.
  • Patients with CVE exhibited a significantly higher PTH ratio compared to event-free patients (p=0.033).
  • A PTH ratio > 1 was associated with a higher incidence of CVE (53% vs. 22%, p=0.013) and shorter event-free survival (p=0.032).
  • Higher PTH ratio independently predicted elevated CVE risk (HR=3.2, p=0.04).

Conclusions:

  • An elevated PTH (1-84)/non-PTH (1-84) ratio is significantly associated with increased cardiovascular risk in hemodialysis patients.
  • The PTH ratio shows promise as a valuable tool for cardiovascular risk stratification in this high-risk group.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.